Literature DB >> 487448

Production of prostaglandin E2 by bladder tumor cells in tissue culture and a possible mechanism of lymphocyte inhibition.

M J Droller, J A Lindgren, H E Claessen, P Perlmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 487448     DOI： 10.1016/0008-8749(79)90336-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  6 in total

1.  Modification of natural killer activity of lymphocytes infiltrating human lung cancers.

Authors:  T M Anderson; Y Ibayashi; E C Holmes; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Inhibition of Nb2 T-lymphoma cell growth by transforming growth factor-beta.

Authors:  E J Rayhel; D A Prentice; P S Tabor; W H Flurkey; R W Geib; R F Laherty; S B Schnitzer; R Chen; J P Hughes
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

3.  Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.

Authors:  D Santoli; P D Phillips; T L Colt; R B Zurier
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 4.  Gene-modified dendritic cells for immunotherapy against cancer.

Authors:  Andreas Lundqvist; Pavel Pisa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

5.  The effect of indomethacin on the activation and effector function of suppressor cells from tumor-bearing mice.

Authors:  B L Pope
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

6.  Anaemia in patients with solid tumours and the role of erythrocyte deformability.

Authors:  C E Mercke
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.